
HY20 result: API (ASX:API) share price down 8%
The Australian Pharmaceutical Industries (ASX:API) share price has fallen 8% in response to the company’s FY20 half year result.
Big money is not in the buying or selling, but in the waiting.
Charlie Munger
For my own portfolio, I like to find ASX shares that are growing their dividends. Growth is an essential part of the dividend equation for me. I want to see that the dividend increases are funded by growing earnings and/or growing underlying asset values. I also have a portion of my portfolio invested in an ETF that picks undervalued global businesses with strong competitive advantages.
For Rask Media, I have an interest in covering technology (and tech-related) businesses with a global growth story, as well as cyclical companies that are cheaply priced because they’re at a low point in the cycle, such as retailers and resource businesses which could benefit strongly in the medium-term.

The Australian Pharmaceutical Industries (ASX:API) share price has fallen 8% in response to the company’s FY20 half year result.

Ramsay Health Care (ASX:RHC) has announced a $1.4 billion capital raising. Should you buy into it?

Is A2 Milk (ASX:A2M) the best ASX growth share at this share price? The infant formula company gave an update today.

Virgin Australia (ASX:VAH) has collapsed into voluntary administration. Now what?

Virgin Australia (ASX:VAH) has gone into voluntary administration. What does this mean for shareholders?

The Nearmap (ASX:NEA) share price is up around 14% after giving an update to investors. Is it still a bargain?

The Sydney Airport (ASX:SYD) share price has fallen around 2% after the business announced another update.

Is the NAB (ASX:NAB) share price a buy after announcing a $1.14 billion profit hit? The NAB share price is down 0.7% right now.

Looking for top dividend shares for 2020 and beyond? The four I mention in this article could be the top picks.
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.